These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22138234)

  • 21. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing accuracy of axillary sentinel lymph node frozen section for breast cancer.
    Jensen AJ; Naik AM; Pommier RF; Vetto JT; Troxell ML
    Am J Surg; 2010 May; 199(5):629-35. PubMed ID: 20466107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Feasibility and accuracy of the combined radioisotope and blue-dye guided sentinel lymph node biopsy in breast cancer].
    Péley G; Farkas E; Téglás M; Orosz Z; Andócs G
    Magy Seb; 2000 Dec; 53(6):241-6. PubMed ID: 11299488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sentinel node biopsy and invasive breast cancer: towards a new minimal surgical approach].
    Nogaret JM; Hertens D; Veys I; Bourgeois P; Larsimont D
    Rev Med Brux; 2002 Jun; 23(3):A175-6. PubMed ID: 12143157
    [No Abstract]   [Full Text] [Related]  

  • 27. Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.
    Wei S; Bleiweiss IJ; Nagi C; Jaffer S
    Clin Breast Cancer; 2014 Aug; 14(4):280-4. PubMed ID: 24581736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
    Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A
    Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hot, blue, suspicious: comment on "Processing sentinel nodes in breast cancer".
    Grant CS
    Arch Surg; 2011 Apr; 146(4):393-4. PubMed ID: 21648114
    [No Abstract]   [Full Text] [Related]  

  • 31. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer.
    Park S; Lee JE; Paik HJ; Ryu JM; Bae SY; Lee SK; Kim SW; Nam SJ
    Clin Breast Cancer; 2017 Feb; 17(1):e19-e29. PubMed ID: 27495997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Removal of two sentinel nodes accurately stages the axilla in breast cancer.
    Kennedy RJ; Kollias J; Gill PG; Bochner M; Coventry BJ; Farshid G
    Br J Surg; 2003 Nov; 90(11):1349-53. PubMed ID: 14598413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical axillary recurrence after sentinel node biopsy in breast cancer: a follow-up study of 220 patients.
    Sanjuàn A; Vidal-Sicart S; Zanón G; Pahisa J; Velasco M; Fernández PL; Santamaría G; Farrús B; Muñoz M; Albanell J; Pons F; Vanrell JA
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):932-6. PubMed ID: 15791433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. False-negative Frozen Section of Sentinel Lymph Node Biopsy in a Chinese Population with Breast Cancer.
    Qiao G; Cong Y; Zou H; Lin J; Wang X; Li X; Li Y; Zhu S
    Anticancer Res; 2016 Mar; 36(3):1331-7. PubMed ID: 26977034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sentinel node biopsy in breast cancer and primary tumor dimension].
    Basta P; Tomaszewska R; Pityński K; Opławski M; Basta A
    Ginekol Pol; 2003 Sep; 74(9):666-70. PubMed ID: 14674105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes of false-negative sentinel node biopsy in patients with breast cancer.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    Br J Surg; 2013 May; 100(6):775-83. PubMed ID: 23436699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A modified sentinel node and occult lesion localization (SNOLL) technique in non-palpable breast cancer: a pilot study.
    Follacchio GA; Monteleone F; Anibaldi P; De Vincentis G; Iacobelli S; Merola R; D'Orazi V; Monti M; Pasta V
    J Exp Clin Cancer Res; 2015 Oct; 34():113. PubMed ID: 26445493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Feasibility of sentinel lymph node biopsy peri-neoadjuvant chemotherapy in breast cancer].
    Zhao J; Song ZW; Huang Y; Hao XP; Liang F; Wang SB; Jin SJ; Yu CZ
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2538-41. PubMed ID: 23158793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.